Richard "Dick" Button was the first man to win two Olympic gold medals in figure skating Lawrence Yee joined PEOPLE in December 2023 as the Senior News Editor, Nights. His work has previously ...

Dick Button was more than the most accomplished men’s figure skater in history. He was one of his sport’s greatest innovators and promoters. Button, winner of two Olympic gold medals and five ...

Outside of the three most dominant clubs (Oklahoma City Thunder, Cleveland Cavaliers and Boston Celtics), the conferences are otherwise wide open for playoff positioning. As Duke's Cooper Flagg ...

Two-time Olympic figure skating gold medalist and acclaimed broadcaster Dick Button passed away on Thursday. He was 95 years old. Button was the first American figure skater to win an Olympic gold ...

Fortress Investment Group is seeking to raise about $1 billion for its latest fund in litigation finance, a sector in which it’s becoming a powerhouse, according to people familiar with the matter.

31. In the Super Bowl LIX host city of New Orleans -- Popeyes' hometown -- this exclusive menu will be available at the newly redesigned flagship restaurant on Canal Street for an extended period ...

The WNBA's newest expansion team, the Toronto Tempo, is hiring former WNBA player Monica Wright Rogers as general manager, according to ESPN's Alexa Philippou and Shams Charania. Rogers previously ...

Fortress Investment Group and Lighthouse Investment Partners agreed to merge their global multistrategy hedge funds and tap each other’s talent to capitalize on the explosive growth of such ...

The New Fortress Energy Inc.-Bond has a maturity date of 3/15/2029 and offers a coupon of 8.7500%. The payment of the coupon will take place 2.0 times per biannual on the 15.09.. The New Fortress ...

How to keep your positive attitude from becoming excessive or dismissive. Maintaining a positive outlook is critical for good leadership. Your optimism can inspire your team, drive creativity, and ...

Fortress Biotech (FBIO) and its majority-owned subsidiary, Helocyte, announced that the first patient was dosed in a multicenter, placebo-controlled and randomized Phase 2 clinical trial to ...